Skip Navigation
NMDP Radiation Injury Treatment Network

The Radiation Injury Treatment Network® (RITN) provides comprehensive evaluation and treatment for victims of radiation exposure or other marrow toxic injuries.

Many of the casualties with radiation injury will be salvageable but require outpatient and/or inpatient care.  Recognizing this, the US National Marrow Donor Program (NMDP), US Navy (Office of Naval Research) and American Society for Blood and Marrow Transplantation (ASBMT) collaboratively developed RITN, which comprises of medical centers with expertise in the management of bone marrow failure, stem cell donor centers and umbilical cord blood banks across the US.

The goals of RITN are:

  1. to develop treatment guidelines for managing hematologic toxicity among victims of radiation exposure,
  2. to educate health care professionals about pertinent aspects of radiation exposure management,
  3. to help coordinate the medical response to radiation events, and
  4. to provide comprehensive evaluation and treatment for victims at participating centers.

 HC Standard for RITN

Click above logo or here to access HC Standard for RITN


Recently added to website:

  • NACCHO/RITN Gap Analysis: Understanding the Shortfalls within Radiation Preparedness - Resources tab-Reference Materials section
  • Nuclear Power Plant FAQ - Resources tab-Reference Materials section

2018 Events and Information

  • ASPR TRACIE Healthcare Challenges after Radiological Incidents Webinar 
    • Discussed the impact of radiological incidents on health and healthcare, and planning strategies related to different incidents
    • Recording - click HERE
  • FY2019 begins October 1, 2019
    • FY2019 Link to application for grant funded RITN exercises sent to RITN centers
    • Q1 conference call - Tuesday, October 2nd, 2pm CT - agenda and call-in information to be sent 9/28
    *NOTE: All details to be sent to RITN as applicable and as they become available
    Privacy  |  Terms of Use  |  Plug-ins & Viewers
    Copyright © 2007-2018 National Marrow Donor Program. All Rights Reserved.